nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2E1—liver cancer	0.666	1	CbGaD
Zopiclone—CYP2C8—Sorafenib—liver cancer	0.00159	0.426	CbGbCtD
Zopiclone—CYP2C9—Sorafenib—liver cancer	0.00111	0.297	CbGbCtD
Zopiclone—Salivary hypersecretion—Epirubicin—liver cancer	0.000686	0.00327	CcSEcCtD
Zopiclone—Cystitis—Epirubicin—liver cancer	0.000682	0.00325	CcSEcCtD
Zopiclone—Anaphylactic shock—Sorafenib—liver cancer	0.000682	0.00325	CcSEcCtD
Zopiclone—Colitis—Epirubicin—liver cancer	0.000678	0.00324	CcSEcCtD
Zopiclone—Infection—Sorafenib—liver cancer	0.000677	0.00323	CcSEcCtD
Zopiclone—Gait disturbance—Doxorubicin—liver cancer	0.00067	0.0032	CcSEcCtD
Zopiclone—Vaginal infection—Epirubicin—liver cancer	0.000667	0.00318	CcSEcCtD
Zopiclone—Coordination abnormal—Doxorubicin—liver cancer	0.000666	0.00318	CcSEcCtD
Zopiclone—Neuropathy—Epirubicin—liver cancer	0.000663	0.00316	CcSEcCtD
Zopiclone—Hiccups—Doxorubicin—liver cancer	0.000654	0.00312	CcSEcCtD
Zopiclone—Hepatocellular injury—Doxorubicin—liver cancer	0.000654	0.00312	CcSEcCtD
Zopiclone—Vaginal inflammation—Doxorubicin—liver cancer	0.000654	0.00312	CcSEcCtD
Zopiclone—Dry eye—Epirubicin—liver cancer	0.000652	0.00311	CcSEcCtD
Zopiclone—Anorexia—Sorafenib—liver cancer	0.00065	0.0031	CcSEcCtD
Zopiclone—Cramps of lower extremities—Epirubicin—liver cancer	0.000649	0.0031	CcSEcCtD
Zopiclone—Dermatitis contact—Doxorubicin—liver cancer	0.000646	0.00308	CcSEcCtD
Zopiclone—Abnormal dreams—Doxorubicin—liver cancer	0.000646	0.00308	CcSEcCtD
Zopiclone—CYP3A4—Sorafenib—liver cancer	0.000644	0.173	CbGbCtD
Zopiclone—Rash maculo-papular—Epirubicin—liver cancer	0.000642	0.00306	CcSEcCtD
Zopiclone—Mouth ulceration—Epirubicin—liver cancer	0.000639	0.00305	CcSEcCtD
Zopiclone—Bladder pain—Epirubicin—liver cancer	0.000639	0.00305	CcSEcCtD
Zopiclone—Cystitis noninfective—Doxorubicin—liver cancer	0.000638	0.00305	CcSEcCtD
Zopiclone—Melaena—Doxorubicin—liver cancer	0.000638	0.00305	CcSEcCtD
Zopiclone—Salivary hypersecretion—Doxorubicin—liver cancer	0.000635	0.00303	CcSEcCtD
Zopiclone—Cystitis—Doxorubicin—liver cancer	0.000631	0.00301	CcSEcCtD
Zopiclone—Colitis—Doxorubicin—liver cancer	0.000628	0.00299	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000621	0.00296	CcSEcCtD
Zopiclone—Hypertonia—Epirubicin—liver cancer	0.000619	0.00295	CcSEcCtD
Zopiclone—Vaginal infection—Doxorubicin—liver cancer	0.000617	0.00294	CcSEcCtD
Zopiclone—Neuropathy—Doxorubicin—liver cancer	0.000614	0.00293	CcSEcCtD
Zopiclone—Mental disability—Epirubicin—liver cancer	0.000613	0.00292	CcSEcCtD
Zopiclone—Dyspnoea—Sorafenib—liver cancer	0.000608	0.0029	CcSEcCtD
Zopiclone—Dry eye—Doxorubicin—liver cancer	0.000604	0.00288	CcSEcCtD
Zopiclone—Lymphadenopathy—Epirubicin—liver cancer	0.000601	0.00287	CcSEcCtD
Zopiclone—Cramps of lower extremities—Doxorubicin—liver cancer	0.0006	0.00286	CcSEcCtD
Zopiclone—Dyspepsia—Sorafenib—liver cancer	0.0006	0.00286	CcSEcCtD
Zopiclone—Rash maculo-papular—Doxorubicin—liver cancer	0.000594	0.00283	CcSEcCtD
Zopiclone—Decreased appetite—Sorafenib—liver cancer	0.000593	0.00283	CcSEcCtD
Zopiclone—Thrombophlebitis—Epirubicin—liver cancer	0.000592	0.00283	CcSEcCtD
Zopiclone—Bladder pain—Doxorubicin—liver cancer	0.000591	0.00282	CcSEcCtD
Zopiclone—Mouth ulceration—Doxorubicin—liver cancer	0.000591	0.00282	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Sorafenib—liver cancer	0.000589	0.00281	CcSEcCtD
Zopiclone—Fatigue—Sorafenib—liver cancer	0.000588	0.00281	CcSEcCtD
Zopiclone—Photosensitivity—Epirubicin—liver cancer	0.000584	0.00279	CcSEcCtD
Zopiclone—Pain—Sorafenib—liver cancer	0.000583	0.00278	CcSEcCtD
Zopiclone—Constipation—Sorafenib—liver cancer	0.000583	0.00278	CcSEcCtD
Zopiclone—Hypertonia—Doxorubicin—liver cancer	0.000573	0.00273	CcSEcCtD
Zopiclone—Eczema—Epirubicin—liver cancer	0.000571	0.00272	CcSEcCtD
Zopiclone—Mental disability—Doxorubicin—liver cancer	0.000567	0.00271	CcSEcCtD
Zopiclone—Gastrointestinal pain—Sorafenib—liver cancer	0.000558	0.00266	CcSEcCtD
Zopiclone—Lymphadenopathy—Doxorubicin—liver cancer	0.000556	0.00265	CcSEcCtD
Zopiclone—Thrombophlebitis—Doxorubicin—liver cancer	0.000548	0.00262	CcSEcCtD
Zopiclone—Increased appetite—Epirubicin—liver cancer	0.000546	0.0026	CcSEcCtD
Zopiclone—Urticaria—Sorafenib—liver cancer	0.000542	0.00258	CcSEcCtD
Zopiclone—Photosensitivity—Doxorubicin—liver cancer	0.00054	0.00258	CcSEcCtD
Zopiclone—Abdominal pain—Sorafenib—liver cancer	0.000539	0.00257	CcSEcCtD
Zopiclone—Body temperature increased—Sorafenib—liver cancer	0.000539	0.00257	CcSEcCtD
Zopiclone—Dermatitis bullous—Epirubicin—liver cancer	0.000537	0.00256	CcSEcCtD
Zopiclone—Eczema—Doxorubicin—liver cancer	0.000528	0.00252	CcSEcCtD
Zopiclone—Diplopia—Epirubicin—liver cancer	0.000513	0.00245	CcSEcCtD
Zopiclone—Osteoarthritis—Epirubicin—liver cancer	0.000513	0.00245	CcSEcCtD
Zopiclone—Increased appetite—Doxorubicin—liver cancer	0.000505	0.00241	CcSEcCtD
Zopiclone—Migraine—Epirubicin—liver cancer	0.000505	0.00241	CcSEcCtD
Zopiclone—Affect lability—Epirubicin—liver cancer	0.000505	0.00241	CcSEcCtD
Zopiclone—Hypersensitivity—Sorafenib—liver cancer	0.000502	0.0024	CcSEcCtD
Zopiclone—Dermatitis bullous—Doxorubicin—liver cancer	0.000496	0.00237	CcSEcCtD
Zopiclone—Face oedema—Epirubicin—liver cancer	0.000495	0.00236	CcSEcCtD
Zopiclone—Asthenia—Sorafenib—liver cancer	0.000489	0.00233	CcSEcCtD
Zopiclone—Mood swings—Epirubicin—liver cancer	0.000486	0.00232	CcSEcCtD
Zopiclone—Pruritus—Sorafenib—liver cancer	0.000482	0.0023	CcSEcCtD
Zopiclone—Ataxia—Epirubicin—liver cancer	0.000482	0.0023	CcSEcCtD
Zopiclone—Dehydration—Epirubicin—liver cancer	0.000477	0.00228	CcSEcCtD
Zopiclone—Diplopia—Doxorubicin—liver cancer	0.000474	0.00226	CcSEcCtD
Zopiclone—Osteoarthritis—Doxorubicin—liver cancer	0.000474	0.00226	CcSEcCtD
Zopiclone—Dry skin—Epirubicin—liver cancer	0.00047	0.00224	CcSEcCtD
Zopiclone—Migraine—Doxorubicin—liver cancer	0.000467	0.00223	CcSEcCtD
Zopiclone—Affect lability—Doxorubicin—liver cancer	0.000467	0.00223	CcSEcCtD
Zopiclone—Hypokalaemia—Epirubicin—liver cancer	0.000467	0.00223	CcSEcCtD
Zopiclone—Diarrhoea—Sorafenib—liver cancer	0.000467	0.00223	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000462	0.0022	CcSEcCtD
Zopiclone—Face oedema—Doxorubicin—liver cancer	0.000458	0.00219	CcSEcCtD
Zopiclone—Gastritis—Epirubicin—liver cancer	0.000454	0.00217	CcSEcCtD
Zopiclone—Muscular weakness—Epirubicin—liver cancer	0.000452	0.00216	CcSEcCtD
Zopiclone—Dizziness—Sorafenib—liver cancer	0.000451	0.00215	CcSEcCtD
Zopiclone—Mood swings—Doxorubicin—liver cancer	0.000449	0.00214	CcSEcCtD
Zopiclone—Ataxia—Doxorubicin—liver cancer	0.000446	0.00213	CcSEcCtD
Zopiclone—Asthma—Epirubicin—liver cancer	0.000443	0.00211	CcSEcCtD
Zopiclone—Dysphagia—Epirubicin—liver cancer	0.000443	0.00211	CcSEcCtD
Zopiclone—Influenza—Epirubicin—liver cancer	0.000443	0.00211	CcSEcCtD
Zopiclone—Dehydration—Doxorubicin—liver cancer	0.000441	0.00211	CcSEcCtD
Zopiclone—Dry skin—Doxorubicin—liver cancer	0.000435	0.00208	CcSEcCtD
Zopiclone—Vomiting—Sorafenib—liver cancer	0.000434	0.00207	CcSEcCtD
Zopiclone—Hypokalaemia—Doxorubicin—liver cancer	0.000432	0.00206	CcSEcCtD
Zopiclone—Rash—Sorafenib—liver cancer	0.00043	0.00205	CcSEcCtD
Zopiclone—Dermatitis—Sorafenib—liver cancer	0.00043	0.00205	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000427	0.00204	CcSEcCtD
Zopiclone—Headache—Sorafenib—liver cancer	0.000427	0.00204	CcSEcCtD
Zopiclone—Bronchitis—Epirubicin—liver cancer	0.000426	0.00203	CcSEcCtD
Zopiclone—Gastritis—Doxorubicin—liver cancer	0.00042	0.002	CcSEcCtD
Zopiclone—Muscular weakness—Doxorubicin—liver cancer	0.000418	0.002	CcSEcCtD
Zopiclone—Dysuria—Epirubicin—liver cancer	0.000414	0.00198	CcSEcCtD
Zopiclone—Asthma—Doxorubicin—liver cancer	0.00041	0.00196	CcSEcCtD
Zopiclone—Influenza—Doxorubicin—liver cancer	0.00041	0.00196	CcSEcCtD
Zopiclone—Dysphagia—Doxorubicin—liver cancer	0.00041	0.00196	CcSEcCtD
Zopiclone—Pollakiuria—Epirubicin—liver cancer	0.000409	0.00195	CcSEcCtD
Zopiclone—Nausea—Sorafenib—liver cancer	0.000405	0.00193	CcSEcCtD
Zopiclone—Photosensitivity reaction—Epirubicin—liver cancer	0.000405	0.00193	CcSEcCtD
Zopiclone—Weight increased—Epirubicin—liver cancer	0.000403	0.00192	CcSEcCtD
Zopiclone—Weight decreased—Epirubicin—liver cancer	0.000401	0.00191	CcSEcCtD
Zopiclone—Drowsiness—Epirubicin—liver cancer	0.000395	0.00189	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—liver cancer	0.000394	0.00188	CcSEcCtD
Zopiclone—CYP3A4—Doxorubicin—liver cancer	0.000391	0.105	CbGbCtD
Zopiclone—Neuropathy peripheral—Epirubicin—liver cancer	0.000387	0.00185	CcSEcCtD
Zopiclone—Stomatitis—Epirubicin—liver cancer	0.000385	0.00184	CcSEcCtD
Zopiclone—Conjunctivitis—Epirubicin—liver cancer	0.000384	0.00183	CcSEcCtD
Zopiclone—Urinary tract infection—Epirubicin—liver cancer	0.000384	0.00183	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—liver cancer	0.000383	0.00183	CcSEcCtD
Zopiclone—Sweating—Epirubicin—liver cancer	0.000379	0.00181	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—liver cancer	0.000379	0.00181	CcSEcCtD
Zopiclone—Haematuria—Epirubicin—liver cancer	0.000377	0.0018	CcSEcCtD
Zopiclone—Photosensitivity reaction—Doxorubicin—liver cancer	0.000374	0.00179	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—liver cancer	0.000373	0.00178	CcSEcCtD
Zopiclone—Epistaxis—Epirubicin—liver cancer	0.000373	0.00178	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—liver cancer	0.000371	0.00177	CcSEcCtD
Zopiclone—Drowsiness—Doxorubicin—liver cancer	0.000366	0.00174	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—liver cancer	0.000358	0.00171	CcSEcCtD
Zopiclone—Stomatitis—Doxorubicin—liver cancer	0.000356	0.0017	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—liver cancer	0.000356	0.0017	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—liver cancer	0.000355	0.0017	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—liver cancer	0.000355	0.0017	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—liver cancer	0.000355	0.00169	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—liver cancer	0.000353	0.00168	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—liver cancer	0.000352	0.00168	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—liver cancer	0.000351	0.00167	CcSEcCtD
Zopiclone—Oedema peripheral—Epirubicin—liver cancer	0.000349	0.00167	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—liver cancer	0.000349	0.00166	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—liver cancer	0.000345	0.00165	CcSEcCtD
Zopiclone—Erythema multiforme—Epirubicin—liver cancer	0.000335	0.0016	CcSEcCtD
Zopiclone—Tinnitus—Epirubicin—liver cancer	0.000331	0.00158	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—liver cancer	0.000329	0.00157	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—liver cancer	0.000328	0.00157	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—liver cancer	0.000327	0.00156	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—liver cancer	0.000326	0.00155	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—liver cancer	0.000323	0.00154	CcSEcCtD
Zopiclone—Chills—Epirubicin—liver cancer	0.000318	0.00152	CcSEcCtD
Zopiclone—Alopecia—Epirubicin—liver cancer	0.000313	0.0015	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—liver cancer	0.00031	0.00148	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—liver cancer	0.000306	0.00146	CcSEcCtD
Zopiclone—Tension—Epirubicin—liver cancer	0.000303	0.00145	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—liver cancer	0.000302	0.00144	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—liver cancer	0.0003	0.00143	CcSEcCtD
Zopiclone—Back pain—Epirubicin—liver cancer	0.000299	0.00143	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—liver cancer	0.000297	0.00142	CcSEcCtD
Zopiclone—Chills—Doxorubicin—liver cancer	0.000295	0.00141	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—liver cancer	0.000291	0.00139	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—liver cancer	0.00029	0.00138	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—liver cancer	0.000287	0.00137	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—liver cancer	0.000285	0.00136	CcSEcCtD
Zopiclone—Agitation—Epirubicin—liver cancer	0.000284	0.00135	CcSEcCtD
Zopiclone—Tension—Doxorubicin—liver cancer	0.00028	0.00134	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—liver cancer	0.00028	0.00134	CcSEcCtD
Zopiclone—Malaise—Epirubicin—liver cancer	0.000278	0.00133	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—liver cancer	0.000278	0.00132	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—liver cancer	0.000277	0.00132	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—liver cancer	0.000276	0.00132	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—liver cancer	0.000275	0.00131	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—liver cancer	0.000273	0.0013	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—liver cancer	0.000269	0.00128	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—liver cancer	0.000268	0.00128	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—liver cancer	0.000267	0.00127	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—liver cancer	0.000265	0.00126	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—liver cancer	0.000264	0.00126	CcSEcCtD
Zopiclone—Chest pain—Epirubicin—liver cancer	0.000263	0.00125	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—liver cancer	0.000263	0.00125	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—liver cancer	0.000263	0.00125	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—liver cancer	0.000262	0.00125	CcSEcCtD
Zopiclone—Discomfort—Epirubicin—liver cancer	0.00026	0.00124	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—liver cancer	0.000258	0.00123	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—liver cancer	0.000257	0.00123	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—liver cancer	0.000257	0.00122	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—liver cancer	0.000254	0.00121	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—liver cancer	0.000252	0.0012	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—liver cancer	0.000252	0.0012	CcSEcCtD
Zopiclone—Infection—Epirubicin—liver cancer	0.00025	0.00119	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—liver cancer	0.000248	0.00118	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—liver cancer	0.000247	0.00118	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—liver cancer	0.000246	0.00117	CcSEcCtD
Zopiclone—Hyperhidrosis—Epirubicin—liver cancer	0.000244	0.00116	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—liver cancer	0.000243	0.00116	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—liver cancer	0.000243	0.00116	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—liver cancer	0.000242	0.00116	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—liver cancer	0.00024	0.00115	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—liver cancer	0.00024	0.00115	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—liver cancer	0.000238	0.00114	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—liver cancer	0.000235	0.00112	CcSEcCtD
Zopiclone—Anaphylactic shock—Doxorubicin—liver cancer	0.000233	0.00111	CcSEcCtD
Zopiclone—Infection—Doxorubicin—liver cancer	0.000232	0.00111	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00023	0.0011	CcSEcCtD
Zopiclone—Insomnia—Epirubicin—liver cancer	0.000228	0.00109	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—liver cancer	0.000228	0.00109	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—liver cancer	0.000226	0.00108	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—liver cancer	0.000225	0.00108	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—liver cancer	0.000225	0.00107	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—liver cancer	0.000224	0.00107	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—liver cancer	0.000222	0.00106	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—liver cancer	0.000222	0.00106	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—liver cancer	0.000219	0.00105	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000218	0.00104	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—liver cancer	0.000217	0.00104	CcSEcCtD
Zopiclone—Constipation—Epirubicin—liver cancer	0.000216	0.00103	CcSEcCtD
Zopiclone—Pain—Epirubicin—liver cancer	0.000216	0.00103	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000212	0.00101	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—liver cancer	0.000211	0.00101	CcSEcCtD
Zopiclone—Paraesthesia—Doxorubicin—liver cancer	0.000209	0.000999	CcSEcCtD
Zopiclone—Dyspnoea—Doxorubicin—liver cancer	0.000208	0.000992	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—liver cancer	0.000208	0.000991	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—liver cancer	0.000207	0.000989	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—liver cancer	0.000206	0.000983	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—liver cancer	0.000205	0.000979	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—liver cancer	0.000203	0.000967	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000201	0.000961	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—liver cancer	0.000201	0.000959	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—liver cancer	0.0002	0.000955	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—liver cancer	0.000199	0.000951	CcSEcCtD
Zopiclone—Pain—Doxorubicin—liver cancer	0.000199	0.000951	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—liver cancer	0.000199	0.000951	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—liver cancer	0.000199	0.000951	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—liver cancer	0.000192	0.000917	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000191	0.00091	CcSEcCtD
Zopiclone—Hypersensitivity—Epirubicin—liver cancer	0.000186	0.000886	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—liver cancer	0.000185	0.000884	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—liver cancer	0.000184	0.00088	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—liver cancer	0.000184	0.00088	CcSEcCtD
Zopiclone—Asthenia—Epirubicin—liver cancer	0.000181	0.000863	CcSEcCtD
Zopiclone—Pruritus—Epirubicin—liver cancer	0.000178	0.000851	CcSEcCtD
Zopiclone—Diarrhoea—Epirubicin—liver cancer	0.000172	0.000823	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—liver cancer	0.000172	0.00082	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—liver cancer	0.000167	0.000798	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—liver cancer	0.000167	0.000795	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—liver cancer	0.000165	0.000787	CcSEcCtD
Zopiclone—Vomiting—Epirubicin—liver cancer	0.00016	0.000765	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—liver cancer	0.00016	0.000761	CcSEcCtD
Zopiclone—Rash—Epirubicin—liver cancer	0.000159	0.000758	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—liver cancer	0.000159	0.000757	CcSEcCtD
Zopiclone—Headache—Epirubicin—liver cancer	0.000158	0.000753	CcSEcCtD
Zopiclone—Dizziness—Doxorubicin—liver cancer	0.000154	0.000736	CcSEcCtD
Zopiclone—Nausea—Epirubicin—liver cancer	0.00015	0.000714	CcSEcCtD
Zopiclone—Vomiting—Doxorubicin—liver cancer	0.000148	0.000707	CcSEcCtD
Zopiclone—Rash—Doxorubicin—liver cancer	0.000147	0.000702	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—liver cancer	0.000147	0.000701	CcSEcCtD
Zopiclone—Headache—Doxorubicin—liver cancer	0.000146	0.000697	CcSEcCtD
Zopiclone—Nausea—Doxorubicin—liver cancer	0.000139	0.000661	CcSEcCtD
Zopiclone—GABRB3—BDNF signaling pathway—HRAS—liver cancer	5.82e-05	0.000481	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—HRAS—liver cancer	5.71e-05	0.000472	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—TAT—liver cancer	5.69e-05	0.00047	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.6e-05	0.000463	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	5.56e-05	0.000459	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.53e-05	0.000457	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—UGDH—liver cancer	5.51e-05	0.000456	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.51e-05	0.000455	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	5.43e-05	0.000449	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	5.35e-05	0.000442	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—RAF1—liver cancer	5.35e-05	0.000442	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.29e-05	0.000438	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—PPARA—liver cancer	5.2e-05	0.00043	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—EPT1—liver cancer	5.18e-05	0.000429	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CPT1B—liver cancer	5.17e-05	0.000427	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GLUL—liver cancer	5.17e-05	0.000427	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—AKT1—liver cancer	5.14e-05	0.000425	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	5.11e-05	0.000422	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—PPARA—liver cancer	5.1e-05	0.000422	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GGT1—liver cancer	5.06e-05	0.000418	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	5.01e-05	0.000415	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NR1H4—liver cancer	4.99e-05	0.000412	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	4.98e-05	0.000412	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—TAT—liver cancer	4.91e-05	0.000406	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTA3—liver cancer	4.9e-05	0.000405	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	4.89e-05	0.000404	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.83e-05	0.0004	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	4.81e-05	0.000397	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—ALB—liver cancer	4.72e-05	0.00039	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—HRAS—liver cancer	4.67e-05	0.000386	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—HRAS—liver cancer	4.58e-05	0.000379	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.54e-05	0.000375	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	4.51e-05	0.000372	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	4.5e-05	0.000372	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—UGDH—liver cancer	4.49e-05	0.000371	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	4.49e-05	0.000371	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTA4—liver cancer	4.48e-05	0.000371	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.48e-05	0.00037	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	4.48e-05	0.00037	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	4.4e-05	0.000363	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.38e-05	0.000362	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—HRAS—liver cancer	4.37e-05	0.000362	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTA2—liver cancer	4.37e-05	0.000361	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	4.28e-05	0.000353	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—RAF1—liver cancer	4.27e-05	0.000353	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—EPT1—liver cancer	4.22e-05	0.000349	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTA1—liver cancer	4.22e-05	0.000348	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.17e-05	0.000345	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NAT2—liver cancer	4.17e-05	0.000345	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.12e-05	0.00034	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.01e-05	0.000331	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—TAT—liver cancer	4e-05	0.000331	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALDOB—liver cancer	4e-05	0.00033	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	3.98e-05	0.000329	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.96e-05	0.000327	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.93e-05	0.000325	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.9e-05	0.000323	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GLUL—liver cancer	3.86e-05	0.000319	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CPT1B—liver cancer	3.86e-05	0.000319	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—ALB—liver cancer	3.86e-05	0.000319	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	3.84e-05	0.000318	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CRABP1—liver cancer	3.81e-05	0.000315	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	3.79e-05	0.000313	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	3.73e-05	0.000308	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NR1H4—liver cancer	3.73e-05	0.000308	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	3.7e-05	0.000306	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—HRAS—liver cancer	3.68e-05	0.000304	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTA3—liver cancer	3.66e-05	0.000303	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	3.64e-05	0.000301	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.62e-05	0.000299	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	3.6e-05	0.000297	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—HRAS—liver cancer	3.58e-05	0.000296	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—HRAS—liver cancer	3.51e-05	0.00029	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	3.49e-05	0.000289	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—HRAS—liver cancer	3.45e-05	0.000285	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.43e-05	0.000284	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	3.43e-05	0.000284	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—HRAS—liver cancer	3.43e-05	0.000283	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	3.37e-05	0.000279	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—HRAS—liver cancer	3.37e-05	0.000278	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTA4—liver cancer	3.35e-05	0.000277	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	3.35e-05	0.000277	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CPT1B—liver cancer	3.34e-05	0.000276	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GLUL—liver cancer	3.34e-05	0.000276	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—HPGDS—liver cancer	3.33e-05	0.000275	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.31e-05	0.000274	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	3.29e-05	0.000272	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTA2—liver cancer	3.27e-05	0.00027	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NR1H4—liver cancer	3.22e-05	0.000266	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	3.18e-05	0.000263	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTA3—liver cancer	3.17e-05	0.000262	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTA1—liver cancer	3.15e-05	0.00026	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NAT2—liver cancer	3.12e-05	0.000258	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.02e-05	0.000249	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALDOB—liver cancer	2.99e-05	0.000247	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.98e-05	0.000246	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PSMA4—liver cancer	2.97e-05	0.000246	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PSMD10—liver cancer	2.97e-05	0.000246	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—UGDH—liver cancer	2.96e-05	0.000245	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.94e-05	0.000243	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—HRAS—liver cancer	2.94e-05	0.000243	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTA4—liver cancer	2.9e-05	0.000239	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GOT2—liver cancer	2.89e-05	0.000239	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	2.87e-05	0.000238	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CRABP1—liver cancer	2.85e-05	0.000236	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.83e-05	0.000234	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTA2—liver cancer	2.82e-05	0.000233	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—EPT1—liver cancer	2.78e-05	0.00023	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTA1—liver cancer	2.72e-05	0.000225	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CPT1B—liver cancer	2.72e-05	0.000225	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GLUL—liver cancer	2.72e-05	0.000225	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP2E1—liver cancer	2.72e-05	0.000225	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NAT2—liver cancer	2.69e-05	0.000223	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—TAT—liver cancer	2.64e-05	0.000218	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.63e-05	0.000217	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NR1H4—liver cancer	2.62e-05	0.000217	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.59e-05	0.000214	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALDOB—liver cancer	2.58e-05	0.000213	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTA3—liver cancer	2.58e-05	0.000213	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYCS—liver cancer	2.54e-05	0.00021	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GGT1—liver cancer	2.49e-05	0.000206	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GOT1—liver cancer	2.49e-05	0.000206	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—HPGDS—liver cancer	2.49e-05	0.000206	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CRABP1—liver cancer	2.46e-05	0.000204	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTA4—liver cancer	2.36e-05	0.000195	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.3e-05	0.00019	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTA2—liver cancer	2.3e-05	0.00019	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—liver cancer	2.24e-05	0.000185	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PSMA4—liver cancer	2.22e-05	0.000183	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PSMD10—liver cancer	2.22e-05	0.000183	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.22e-05	0.000183	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTA1—liver cancer	2.22e-05	0.000183	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—HMOX1—liver cancer	2.21e-05	0.000183	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NAT2—liver cancer	2.19e-05	0.000181	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GOT2—liver cancer	2.16e-05	0.000178	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—HPGDS—liver cancer	2.15e-05	0.000178	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.14e-05	0.000177	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.11e-05	0.000174	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALDOB—liver cancer	2.1e-05	0.000174	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTM1—liver cancer	2.06e-05	0.00017	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CRABP1—liver cancer	2e-05	0.000166	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP1A1—liver cancer	1.95e-05	0.000161	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.95e-05	0.000161	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.92e-05	0.000159	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PSMA4—liver cancer	1.92e-05	0.000159	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PSMD10—liver cancer	1.92e-05	0.000159	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYCS—liver cancer	1.9e-05	0.000157	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GOT2—liver cancer	1.87e-05	0.000154	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GGT1—liver cancer	1.86e-05	0.000154	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GOT1—liver cancer	1.86e-05	0.000154	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—MTHFR—liver cancer	1.82e-05	0.00015	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.8e-05	0.000149	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GLUL—liver cancer	1.79e-05	0.000148	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CPT1B—liver cancer	1.79e-05	0.000148	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPARA—liver cancer	1.79e-05	0.000148	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2E1—liver cancer	1.75e-05	0.000145	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HPGDS—liver cancer	1.75e-05	0.000145	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.74e-05	0.000144	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NR1H4—liver cancer	1.73e-05	0.000143	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA3—liver cancer	1.7e-05	0.000141	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.7e-05	0.00014	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—liver cancer	1.67e-05	0.000138	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—HMOX1—liver cancer	1.65e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYCS—liver cancer	1.64e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GGT1—liver cancer	1.61e-05	0.000133	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GOT1—liver cancer	1.61e-05	0.000133	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.6e-05	0.000133	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.59e-05	0.000131	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.57e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PSMA4—liver cancer	1.56e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PSMD10—liver cancer	1.56e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA4—liver cancer	1.55e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTM1—liver cancer	1.54e-05	0.000127	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CG—liver cancer	1.53e-05	0.000126	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GOT2—liver cancer	1.52e-05	0.000126	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA2—liver cancer	1.51e-05	0.000125	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPARG—liver cancer	1.48e-05	0.000122	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTA1—liver cancer	1.46e-05	0.000121	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP1A1—liver cancer	1.46e-05	0.000121	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—liver cancer	1.45e-05	0.00012	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NAT2—liver cancer	1.45e-05	0.000119	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2E1—liver cancer	1.43e-05	0.000118	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—HMOX1—liver cancer	1.43e-05	0.000118	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALDOB—liver cancer	1.39e-05	0.000115	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.38e-05	0.000114	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—MTHFR—liver cancer	1.36e-05	0.000112	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CD—liver cancer	1.34e-05	0.000111	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYCS—liver cancer	1.34e-05	0.00011	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPARA—liver cancer	1.33e-05	0.00011	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTM1—liver cancer	1.33e-05	0.00011	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ALB—liver cancer	1.33e-05	0.00011	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CRABP1—liver cancer	1.32e-05	0.000109	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GGT1—liver cancer	1.31e-05	0.000108	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GOT1—liver cancer	1.31e-05	0.000108	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP1A1—liver cancer	1.26e-05	0.000104	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—liver cancer	1.18e-05	9.74e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—MTHFR—liver cancer	1.18e-05	9.72e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CB—liver cancer	1.17e-05	9.68e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—HMOX1—liver cancer	1.16e-05	9.6e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HPGDS—liver cancer	1.16e-05	9.55e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPARA—liver cancer	1.15e-05	9.53e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CG—liver cancer	1.14e-05	9.44e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPARG—liver cancer	1.1e-05	9.11e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTM1—liver cancer	1.08e-05	8.95e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.04e-05	8.56e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PSMA4—liver cancer	1.03e-05	8.51e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PSMD10—liver cancer	1.03e-05	8.51e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP1A1—liver cancer	1.03e-05	8.48e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CD—liver cancer	1e-05	8.3e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GOT2—liver cancer	1e-05	8.28e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ALB—liver cancer	9.91e-06	8.2e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CG—liver cancer	9.87e-06	8.16e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—MTHFR—liver cancer	9.57e-06	7.91e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPARG—liver cancer	9.53e-06	7.88e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2E1—liver cancer	9.42e-06	7.79e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPARA—liver cancer	9.38e-06	7.76e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYCS—liver cancer	8.81e-06	7.28e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CB—liver cancer	8.75e-06	7.24e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CD—liver cancer	8.68e-06	7.18e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GOT1—liver cancer	8.65e-06	7.15e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GGT1—liver cancer	8.65e-06	7.15e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ALB—liver cancer	8.57e-06	7.08e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.43e-06	6.97e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CG—liver cancer	8.04e-06	6.64e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—liver cancer	7.77e-06	6.42e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPARG—liver cancer	7.76e-06	6.41e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—HMOX1—liver cancer	7.66e-06	6.33e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CB—liver cancer	7.57e-06	6.25e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CA—liver cancer	7.14e-06	5.9e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTM1—liver cancer	7.14e-06	5.9e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CD—liver cancer	7.07e-06	5.84e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ALB—liver cancer	6.97e-06	5.77e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP1A1—liver cancer	6.77e-06	5.59e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—MTHFR—liver cancer	6.31e-06	5.21e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPARA—liver cancer	6.19e-06	5.12e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CB—liver cancer	6.16e-06	5.09e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—AKT1—liver cancer	5.83e-06	4.82e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CA—liver cancer	5.34e-06	4.41e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CG—liver cancer	5.3e-06	4.38e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPARG—liver cancer	5.12e-06	4.23e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CD—liver cancer	4.66e-06	3.85e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CA—liver cancer	4.61e-06	3.81e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ALB—liver cancer	4.6e-06	3.8e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—AKT1—liver cancer	4.36e-06	3.6e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CB—liver cancer	4.06e-06	3.36e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—AKT1—liver cancer	3.77e-06	3.11e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CA—liver cancer	3.75e-06	3.1e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—AKT1—liver cancer	3.07e-06	2.54e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CA—liver cancer	2.48e-06	2.05e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—AKT1—liver cancer	2.02e-06	1.67e-05	CbGpPWpGaD
